Literature DB >> 7793475

Fibrous dysplasia and cemento-ossifying fibroma. A histologic spectrum.

T M Voytek1, J Y Ro, J Edeiken, A G Ayala.   

Abstract

Fibrous dysplasia (FD) and cemento-ossifying fibroma (COF) are benign fibro-osseous lesions that are generally considered to be separate entities, distinguished by histologic and radiographic features. In our experience, some lesions lack the classic clinical, radiographic, or pathologic features of FD or COF and rather have overlapping features of both entities. Consequently, these cases are frequently diagnosed nonspecifically as fibro-osseous lesions. We examined 56 gnathic and extragnathic fibro-osseous lesions of bone morphologically, clinically, and radiographically to determine whether they can be reliably distinguished and whether their distinction has any clinical or prognostic significance. The lesions exhibited a broad morphologic spectrum of patterns ranging from pure FD (24 cases) to pure COF (10 cases). Twenty-two lesions contained a mixture of both patterns; 11 lesions with a predominant FD pattern contained calcified spherules histologically indistinguishable from those characteristically seen in COF. The remaining 11 lesions contained areas of typical FD adjacent to areas of COF. The lesions examined also demonstrated considerable radiographic overlap, and FD could not be reliably distinguished from COF. The recurrence rate was low for all lesions regardless of the histologic pattern. Because of histologic and radiographic overlap and similar low recurrence rate of FD and COF, we consider them to be related lesions, and COF is probably an opposing end of a morphologic spectrum of FD.

Entities:  

Mesh:

Year:  1995        PMID: 7793475

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  16 in total

1.  Analysis of GNAS mutations in cemento-ossifying fibromas and cemento-osseous dysplasias of the jaws.

Authors:  Milan M Patel; Jonathan F Wilkey; Rafik Abdelsayed; Nisha J D'Silva; Carl Malchoff; Sanjay M Mallya
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-03-25

2.  Juvenile trabecular ossifying fibroma: an update.

Authors:  Pieter J Slootweg
Journal:  Virchows Arch       Date:  2012-10-10       Impact factor: 4.064

Review 3.  Fibro-osseous lesions of the maxillofacial bones.

Authors:  Edward F McCarthy
Journal:  Head Neck Pathol       Date:  2013-03-05

4.  Chromosome 12 long arm rearrangement covering MDM2 and RASAL1 is associated with aggressive craniofacial juvenile ossifying fibroma and extracranial psammomatoid fibro-osseous lesions.

Authors:  Flore Tabareau-Delalande; Christine Collin; Anne Gomez-Brouchet; Corinne Bouvier; Anne-Valérie Decouvelaere; Anne de Muret; Jean-Christophe Pagès; Gonzague de Pinieux
Journal:  Mod Pathol       Date:  2014-06-13       Impact factor: 7.842

5.  Unusual radiographic appearance of ossifying fibroma in the left mandibular angle.

Authors:  M Araki; K Matsumoto; N Matsumoto; K Honda; H Ohki; K Komiyama
Journal:  Dentomaxillofac Radiol       Date:  2010-07       Impact factor: 2.419

6.  Cemento-ossifying fibroma of jaws-correlation of clinical and pathological findings.

Authors:  Jelena Sopta; Radojica Dražić; Goran Tulić; Vesna Mijucić; Zvezdana Tepavčević
Journal:  Clin Oral Investig       Date:  2010-02-12       Impact factor: 3.573

7.  Trabecular and psammomatoid juvenile ossifying fibroma of the skull base mimicking psammomatoid meningioma.

Authors:  Olga L Bohn; John R Kalmar; Carl M Allen; Claudia Kirsch; Dayna Williams; Marino E Leon
Journal:  Head Neck Pathol       Date:  2010-10-16

8.  Bone diseases of the jaws.

Authors:  Pieter Johannes Slootweg
Journal:  Int J Dent       Date:  2010-03-31

9.  Retrospective Analysis of Ossifying Fibroma of Jaw Bones Over a Period of 10 Years with Literature Review.

Authors:  Sujata Mohanty; Sunita Gupta; Priya Kumar; K Sriram; Ujjwal Gulati
Journal:  J Maxillofac Oral Surg       Date:  2013-06-16

Review 10.  [The activating GNAS mutation : A survey of fibrous dysplasia, its associated syndromes, and other skeletal and extraskeletal lesions].

Authors:  H Ostertag; S Glombitza
Journal:  Pathologe       Date:  2018-03       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.